LMR Partners’s LAVA Medtech Acquisition Corp. Warrants LVACW Stock Holding History

LMR Partners’s Portfolio LVACW Stock Details LVACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-12,500	Closed	-$130K	–	1238
2023 Q1	$130K	Hold	12,500	–	–	﹤0.01%	909
2022 Q4	$127K	Buy	+12,500	New	+$615	﹤0.01%	1025

LMR Partners's LVACW Position: Q2 2023 in Review

LMR Partners sold out of LAVA Medtech Acquisition Corp. Warrants (LVACW) in Q2 2023, closing a stake of 12,500 shares — an estimated $130K sold.

LMR Partners first reported a position in LVACW in Q4 2022 and held it in 2 quarters. The position peaked at $130K in Q1 2023. 0 funds tracked by Wall St. Rank hold LVACW as of Q2 2023.

LMR Partners reported no remaining LAVA Medtech Acquisition Corp. Warrants position as of Q2 2023 after selling out during the quarter.
LMR Partners sold 12,500 LAVA Medtech Acquisition Corp. Warrants shares in Q2 2023, an estimated $130K.
LMR Partners first reported a position in LAVA Medtech Acquisition Corp. Warrants in Q4 2022 and held it in 2 quarters.
LMR Partners's LAVA Medtech Acquisition Corp. Warrants position peaked at $130K in Q1 2023.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Warrants as of Q2 2023.

Based on LMR Partners's 13F filing for Q2 2023, filed 14 Aug 2023.